首页> 美国卫生研究院文献>other >EGF RECEPTOR SIGNALING IS ESSENTIAL FOR K-RAS ONCOGENE-DRIVEN PANCREATIC DUCTAL ADENOCARCINOMA
【2h】

EGF RECEPTOR SIGNALING IS ESSENTIAL FOR K-RAS ONCOGENE-DRIVEN PANCREATIC DUCTAL ADENOCARCINOMA

机译:EGF受体信号传导是必不可少的K-Ras癌基因驱动的胰腺导管腺癌

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Clinical evidence indicates that mutation/activation of EGF receptors (EGFRs) is mutually exclusive with the presence of K-RAS oncogenes in lung and colon tumors. We have validated these observations using genetically engineered mouse models. However, pancreatic ductal adenocarcinomas driven by K-Ras oncogenes are totally dependent on EGFR signaling. Similar results were obtained using human pancreatic tumor cell lines. EGFRs were also essential even in the context of pancreatic injury and absence of p16Ink4a/p19Arf. Only loss of p53 made pancreatic tumors independent of EGFR signaling. Additional inhibition of PI3K and STAT3 effectively prevented proliferation of explants derived from these p53–defective pancreatic tumors. These findings may provide the bases for more rational approaches to treat pancreatic tumors in the clinic.
机译:临床证据表明,EGF受体(EGFR)的突变/激活与肺和结肠肿瘤中K-RAS癌基因的存在相互排斥。我们已经使用基因工程小鼠模型验证了这些观察结果。然而,由K-Ras致癌基因驱动的胰腺导管腺癌完全依赖于EGFR信号传导。使用人胰腺肿瘤细胞系获得了相似的结果。即使在胰腺损伤和缺少p16Ink4a / p19Arf的情况下,EGFR也是必不可少的。仅p53的丧失使胰腺肿瘤独立于EGFR信号传导。对PI3K和STAT3的额外抑制有效地阻止了源自这些p53缺陷型胰腺肿瘤的外植体的增殖。这些发现可能为临床上更合理地治疗胰腺肿瘤提供基础。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号